Home buprenorphine/naloxone induction in primary care

Area of Science:

• Addiction Medicine
• Primary Care
• Pharmacology

Background:

• Buprenorphine is used for opioid dependence treatment in primary care.
• National guidelines recommend observed initial dosing and frequent clinic visits.
• This study explored a home, unobserved induction protocol for buprenorphine treatment.

Purpose of the Study:

• To assess the feasibility and safety of a home-based, unobserved buprenorphine induction protocol.
• To evaluate induction-related complications and treatment retention at week 1.
• To compare home induction outcomes with traditional in-clinic protocols.

Main Methods:

• 103 opioid-dependent adults received an initial physician visit with education and a 1-week prescription.
• Patients initiated buprenorphine/naloxone dosing at home, without direct observation.
• Follow-up included urine toxicology and assessment of withdrawal symptoms and adverse events.

Main Results:

• 73% of patients were retained in treatment at week 1.
• No severe precipitated withdrawal or serious adverse events (SAEs) were observed.
• Mild-to-moderate withdrawal symptoms occurred in 5% of patients; prolonged withdrawal in 8%.

Conclusions:

• Home buprenorphine induction is a feasible and safe alternative to observed induction.
• Induction complications occurred at expected rates and did not negatively impact short-term treatment retention.
• This protocol offers a practical approach for primary care settings.